Generic Name Brand Name Restrictions or Notes 1a. ANTIRETROVIRALS-ENTRY INHIBITORS (2) 1b. ANTIRETROVIRALS-INTEGRASE INHIBITOR(3)

Similar documents
Generic Name Brand Name Restrictions or Notes 1a. ANTIRETROVIRALS-ENTRY INHIBITORS (1) 1b. ANTIRETROVIRALS-INTEGRASE INHIBITOR(2)

FORMULARY Virginia (VA) AIDS Drug Assistance Program (ADAP) LAST UPDATED: December At a Glance: VA ADAP Formulary

ALABAMA S ADAP FORMULARY OFFERS 117 MEDICATIONS

HIV Drugs and the HIV Lifecycle

Daclatasvir (Daklinza ) Drug Interactions with HIV Medications

Division of Public Health Services Office of the Assistant Director Public Health Preparedness Services

HIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet tablet daily. Complera 200/25/300 mg tablet tablet daily

AIDS DRUG ASSISTANCE PROGRAM (ADAP) FORMULARY - CLIENT VERSION

REIMBURSEMENT STATUS OF HIV MEDICATIONS IN ONTARIO

WOMEN'S INTERAGENCY HIV STUDY METABOLIC STUDY: MS01 SPECIMEN COLLECTION FORM

WOMENS INTERAGENCY HIV STUDY ANTIRETROVIRAL DOSAGE FORM SECTION A. GENERAL INFORMATION

THE HIV LIFE CYCLE. Understanding How Antiretroviral Medications Work

ANTIRETROVIRAL TREATMENTS (Part 1of

Fluconazole dimenhydrinate, diphenhydramine. Raltegravir or dolutegravir with antacids

Sculpting a Better Regimen: The ART of HIV Medications

AIDS Drug Assistance Program ADAP-Miami. NEEDS ASSESSMENT July 16, 2010

Antiretrovial Crushable/Liquid Formulation Chart

PRIOR ADAP FORMULARY - RX OPTIONS

HIV Management Update 2015

Antiretroviral Dosing in Renal Impairment

Amitriptyline Hydrochloride Heart Health & BP Amlodipine Besylate 5mg Norvasc Antibiotics Amoxicillin 500 mg Amoxil

ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals

Appropriate Use & Safety Edits

Amitriptyline Hydrochloride Heart Health & BP Amlodipine Besylate 5mg Norvasc Antibiotics Amoxicillin 500 mg Amoxil

Recommended Comparator Products: Medicines for HIV/AIDS and Related Diseases

Drug Treatment Program Update

Recommended comparator products: Medicines for HIV/AIDS and related diseases

COMPREHENSIVE ANTIRETROVIRAL TABLE: ADULT DOSING, DOSAGE FORM MODIFICATIONS, ADVERSE REACTIONS and INTERACTION POTENTIAL

COMPREHENSIVE ANTIRETROVIRAL TABLE: ADULT DOSING**, DOSAGE FORM MODIFICATIONS, ADVERSE REACTIONS and INTERACTION POTENTIAL

May 2016 P & T Updates

Guidance for Non-HIV-Specialized Providers Caring for Persons with HIV Displaced by Disasters

HIV medications HIV medication and schedule plan

5 Infections. To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and

Medication Guide. October Contents. Preferred Medication List

Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) in the Long Term Care Setting Part 2: HIV Medications

JULUCA (dolutegravir sodium-rilpivirine hydrochloride) oral tablet

The ART of Antiretroviral Therapy in Critically-ill Patients with HIV

An HIV Update Jan Clark, PharmD Specialty Practice Pharmacist

MEDICATION RELATED ISSUES IN THE HIV PATIENT. LEONARD SOWAH, MBChB, MPH, FACP

Medication Errors Focus on the HIV-Infected Patient

HIV Treatment Update. Objectives. Epidemiology 12/22/2015

Section H: Treatments

Exploring HIV in 2017: What a pharmacist needs to know

Northwest AIDS Education and Training Center Educating health care professionals to provide quality HIV care

The ART of Managing Drug-Drug Interactions in Patients with HIV

treatment passport 1

Simplifying HIV Treatment Now and in the Future

Selecting an Initial Antiretroviral Therapy (ART) Regimen

October 26-28: Training Day 1

Gilead Sciences, LLC 50

1. Procedure for this Invitation to EOI. 2. Medicinal products included on the 14 th Invitation. Guidance Document 14 May 2016

The ABCs of ART: Designing Initial Antiretroviral Regimens for Beginners

Nothing to disclose.

ABRIDGED ANTIRETROVIRAL TABLE: ADULT DOSING, DOSAGE FORM MODIFICATIONS, ADVERSE REACTIONS and INTERACTION POTENTIAL

Midwestern Underwriting Conference 2016

Table 1: Price increases for Brand Name Drugs with Generic Equivalents

ADAP Monitoring Provider Prescribing Patterns. Amanda Bowes, NASTAD Christine Rivera and Dr. Charles Gonzalez, NYS AIDS Institute


HIV Infection & AIDS in Low- and Middle-Income Countries

HIV THERAPY STRATEGIES FOR THIRD LINE. issues to consider when faced with few drug options

Approach for the Newly Diagnosed HIV Positive Patient

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 03/07/18 SECTION: DRUGS LAST REVIEW DATE: 02/19/19 LAST CRITERIA REVISION DATE: ARCHIVE DATE:

Matters of the HAART: An Update on Current Treatment Options for HIV

continuing education for pharmacists

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 9 May 2012

Penicillin VK Vcillin K 250gm/5ml Penicillin VK Vcillin K 250mg Sulfameth/Trimeth Bactrim 400/80mg Sulfameth/Trimeth Bactrim/Septra DS 800/160mg

Didactic Series. Switching Regimens in the Setting of Virologic Suppression

Bristol-Myers Squibb and Gilead Sciences, LLC 50

HIV Treatment Guidelines

PsychotroPic and Vih January 2014

Approach to a Patient Newly Diagnosed with HIV, Including ART Basics Rajesh T. Gandhi, M.D.

Health Insurance Marketplace 6 Tier Drug List

HIV Pharmacology 101ish - 202ish: New HIV Clinicians Workshop

GENERIC DISCOUNT FORMULARY March 2015

The Future of HIV: Advances in Drugs and Research. Shauna Gunaratne December 17, 2018

2017 Formulary Changes Year to Date

Riesbeck's Pharmacy Reward Club Generic Medication List October 2017

CareHere, LLC Pasco County ISD

HIV Today: Examining the Latest Treatment Advances, Barriers to Care, and Pharmacists Implications

Medication Guide. July Contents. Click to search for a drug name in this document

Jonathan Cohn MD Wayne State University July 24,

2015 OPSC Annual Convention. syllabus. February 4-8, 2015 Hyatt Regency Mission Bay San Diego, California

Professionalism & Service with Great Prices

Riesbeck's Pharmacy Reward Club Generic Medication List February 2018 $4 30 Day Supply

BHIVA ART Guideline 2014 update: SEARCH PROTOCOL: main databases search

Risk of HIV-1 low level viremia to treatment. Germany. Nadine Lübke Düsseldorf

FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS

PDF created with pdffactory trial version

0.14 ( 0.053%) UNAIDS 10% (94) ( ) (73-94/6 ) 8,920

Updated Guidelines for Managing HIV/HCV Co-Infection

Riesbeck's Pharmacy Reward Club Generic Medication List September 2017

Special Generic Drug Pricing Program

HIV THERAPY STRATEGIES FOR FIRST LINE. issues to think about when going on therapy for the first time

FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS

General products list. NDC Product Description Strength Form Brand Name Therapeutic Class Class Size

FORMULARY Revised January 2019

An Update on HIV Therapy Protease Inhibitors for Treatment Experienced Patients

Transcription:

1a. ANTIRETROVIRALS-ENTRY INHIBITORS (2) maraviroc Selzentry 1b. ANTIRETROVIRALS-INTEGRASE INHIBITOR(3) raltegravir Isentress, Isentress HD dolutegravir Tivicay 1c. ANTIRETROVIRALS-NUCLEOSIDE& NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS (NRTI)(12) abacavir Ziagen abacavir/lamivudine Epzicom abacavir/lamivudine/zidovudine Trizivir Non-formulary 1/1/2019 emtricitabine Emtriva emtricitabine/tenofovir alafenamide Descovy lamivudine Epivir, Epivir HBV lamivudine/zidovudine Combivir tenofovir disoproxil fumarate Viread tenofovir/emtricitabine Truvada zidovudine Retrovir, AZT 1d. ANTIRETROVIRALS-NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NNRTI)(5) efavirenz Sustiva etravirine Intelence nevirapine Viramune rilpivirine Edurant 1e. ANTIRETROVIRALS HIV-1 INTEGRASE STRAND TRANSFER INHIBITOR/NRTI COMBINATION(3) bictegravir-emtricitabine-tenofovir AF Biktarvy dolutegravir/lamivudine/ abacavir Triumeq elvitegravir/cobicistat/ emtricitabine/tenofovir Stribild elvitegravir/cobicistat/ emtricitabine/tenofovir alafenamide Genvoya 1f. ANTIRETROVIRALS NNRTI/NRTI COMBINATION (3) emtricitabine/tenofovir/efavirez Atripla emtricitabine/tenofovir/rilpivirine Complera emtricitabine/rilpivirine/ tenofovir alafenamide Odefsey 1g. ANTIRETROVIRALS CYP3A/INHIBITOR (1) cobicistat Tybost Page 1 of 5

1h. ANTIRETROVIRALS PROTEASE INHIBITORS (9) atazanavir Reyataz darunavir Prezista fosamprenavir Lexiva lopinavir/ritonavir Kaletra nelfinavir Viracept ritonavir Norvir saquinavir Invirase 1i. ANTIRETROVIRALS-CYP3A INHIBITOR/PROTEASE INHIBITOR (2) darunavir/cobicistat Prezcobix atazanavir/cobicistat Evotaz 1j. ANTIRETROVIRALS HIV-1 INTEGRASE STRAND TRANSFER INHIBITOR/NNRTI COMBINATION(1) dolutegravir/rilprivirine Juluca 2. ANALGESICS ANALGESICS: NON- NARCOTIC ANALGESICS Ibuprofen Motrin naproxen Naprosyn 3. ANTIBIOTICS amoxicillin clavulanate Augmentin azithromycin Zithromax ciprofloxacin Cipro clarithromycin Biaxin, Biaxin XL clindamycin HCL Cleocin doxycycline Vibramycin ethambutol Myambutol levofloxacin Levaquin pyrimethamine Pyrimethamine rifabutin Mycobutin sulfadiazine Sulfadiazine moxifloxacin Avelox primaquine phosphate Primaquine nitazoxanide Alinia paromomycin Humatin cefpodoxime proxetil Vantin 4. ANTICONVULSANTS phenytoin Dilantin divalproex Sodium Depakote gapentin Neurontin Page 2 of 5

5. ANTICOAGULANTS enoxaparin sodium Lovenox apixaban Eliquis warfarin sodium Warfadin 6. ANTIDEPRESSANTS/ANTIPSYCHOTICS/AGENTS OF SLEEP amitriptyline HCL Elavil aripiprazole Abilify asenapine Saphris bupropion SR Wellbutrin, Zyban citalopram Celexa duloxetine Cymbalta escitalopram Lexapro lithium Lithium mirtazapine Remeron paroxetine Paxil sertraline Zoloft trazodone Desyrel venlafaxine ER Effexor XR ziprasidone Geodon 7. ANTIDIARRHEAL diphenoxylate/atropine Lomotil loperamide Imodium 8. ANTIEMETICS ondansetron Zofran prochlorperazine Compazine dronabinol Marinol scopolamine transdermal Trasderm Scop 9. ANTIFUNGALS clotrimazole Mycelex, Lotrimin fluconazole Diflucan itraconazole Sporanox posaconazole Noxafil terbinafine Lamisil 10. ANTIHISTAMINES loratadine Claritin cetirizine Zyrtec Page 3 of 5

11. ANTIHYPERTENSIVES/CARDIAC MEDICATIONS amlodipine Norvasc atenolol Tenormin, senormin hydrochlorothiazide lisinopril Prinivil, Zestril losartan Cozaar losartan / hydrochlorothiazide Hyzaar spironolactone Aldactone 12. ANTIVIRALS aldara cream Imiquimod acyclovir Zovirax valacyclovir Valtrex valganciclovir Valcyte leucovorin Wellcovorin 13. GASTROINTESTINAL AGENTS omeprazole Prilosec, Zegerid 14. H2- ANTAGONISTS famotidine Pepcid 15. HEMATOPOIETIC AGENTS filgrastim Neupogen epoetin alfa (erythropoetin) Procrit, Epogen 16. HORMONE REPLACEMENT THERAPY Androgens testosterone Androgel testosterone cypionate Depo-testosterone oxandrolone Oxandrin Progestins micronized progesterone Prometrium Estrogens/Estrogenic Agents estrogens, conjugated Premarin estradiol estradiol cypionate IM Depo-Estradiol 17. HYPOGLYCEMICS metformin Glucophage glyburide DiaBeta, Micronase, pioglitazone Actos 18. INHALERS/BRONCHODILATORS/ORAL STERIODS/ASTHMA PROPHYLAXIS beclomethasone dipropionate QVAR albuterol Proair fluticasone-salmeterol Advair Discus 250/50 triamcinolone nasal aerosol susp Nasacort Page 4 of 5

19. LIPID LOWERING AGENTS fenofibrate Tricor gemfibrozil Lopid niacin Niaspan atorvastatin Lipitor omega-3-acid ethyl esters Lovaza pitavastatin Livalo 20. OSTEOPENIA/OSTEOPOROSIS alendronate Fosamax 21. PCP PROPHYLAXIS atovaquone Mepron dapsone Dapsone sulfamethoxazole-trimethoprim beta methasone/diprolene ointment megestrol acetate nystatin pancreatic enzymes ( pancrelipase) triamcinolone ointment & cream Bactrim 22. TOPICALS Megace Ultrase MT-20 Program Dispensing Policies 1. All Brands will be covered when a drug is listed on the formulary 2. Drugs marked with are to be dispensed with a minimum 28 day supply. 3. Refills may be obtained after 80% of the previously dispensed days-supply has been used (Nevada ADAP allows up to 6 days prior); however, there is an annual maximum of 13 fills or 390 day supply per prescription. 4. Only one lost fill will be allowed per calender year 5. Non-formulary drugs are not covered if not listed on the Nevada ADAP Formulary. 6. Use of generic products is required when available, unless otherwise specified by clinician. 7. On the use of specific antiretroviral combinations and dosages, adjudication rules have been set to meet treatment guidelines as recommended by the Department of Health and Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and Adolescents Page 5 of 5